Clinical Trials Logo
  1. Home
  2. Vulvar Lichen Sclerosus
  3. NCT06132919

Efficacy and Safety of MC2-25 Cream & Vehicle in Women With Vulvar Lichen Sclerosus (VLS) — Orchid 1  

Vulvar Lichen Sclerosus Clinical Trial

Official title:
A Parallel Group (2-arm), Randomised, Double-blind, 12-week Trial to Explore the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in Women Diagnosed With Vulvar Lichen Sclerosus (VLS)

Clinical Trial Summary

The purpose of this study is to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women with vulvar lichen schelosus (VLS).

Clinical Trial Description

In this study, subjects who fulfil all inclusion and exclusion criteria are enrolled. Eligible subjects will be randomized in a 1:1 ratio to MC2-25 cream or MC2-25 vehicle, respectively. The subjects will apply the assigned investigational medicinal product (IMP) daily for 12 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06132919
Study type Interventional
Source MC2 Therapeutics
Contact Maj Dinesen, MD
Phone +45 2851 9302
Email mdi@mc2therapeutics.com
Status Recruiting
Phase Phase 2
Start date October 11, 2023
Completion date November 10, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03961126 - Evaluation of Vulvar Lichen Sclerosus Treatment Using Adipose Tissue Associated With Autologous Platelet-rich Plasma. Phase 2
Completed NCT03686800 - The Comfort and Adherence of Rivelin® Plain Patches in Vulva Lichen Sclerosus Patients N/A
Completed NCT05147129 - Characterizing the Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus
Completed NCT02573883 - Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus Phase 3
Completed NCT04952961 - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study N/A
Terminated NCT01126255 - Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus Phase 2
Recruiting NCT04951206 - Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus Phase 4
Recruiting NCT05250466 - A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia N/A
Active, not recruiting NCT03926299 - Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus N/A
Completed NCT04148651 - The CO2RE® System for Vulvar Lichen Sclerosus N/A
Completed NCT02416531 - Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser N/A
Recruiting NCT04967170 - A Study to Evaluate Platelet Rich Plasma to Treat Vulvar Lichen Sclerosus Phase 1/Phase 2
Terminated NCT04134494 - Laser Treatment for Vulvar Lichen Sclerosus N/A
Completed NCT05251220 - Efficacy and Safety of the Neodymium Laser in Treatment of Urogenital Tract Diseases in Women
Completed NCT01400022 - Topical 0.05% Clobetasol Propionate in Vaseline Versus UVA-1 Phototherapy in Vulvar Lichen Sclerosus N/A
Recruiting NCT06360705 - StrataMGT for the Treatment of Vulvar Lichen Sclerosus N/A
Completed NCT00757874 - Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus Phase 2
Recruiting NCT05243563 - Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone? Phase 2/Phase 3